Updated 11 hours ago Ozempic Kidney Trial Sinks Dialysis Stocks By WSJ Staff Source: finance.yahoo.com Related posts:Kinder Morgan misses quarterly profit estimates, remains bullish on natgas demandEcopetrol confirms purchase of Repsol’s 45% stake in block CPO 09Volkswagen Is One of the Cheapest Stocks. A Porsche IPO Could Change That.Fed and Peers Will Go Ahead With Rate Cuts After This Week’s US ElectionCanopy Growth swings to big loss as revenue falls 19% Post navigation A Tesla Model 3 for $24,000? It’s Possible If You Can Navigate Tax Credits. Banker says Trump’s financial statements were key to loan approvals, but there were ‘sanity checks’
